|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
AMAG Pharmaceuticals, Inc.
| | | Phone: | (800) 588-6377 | Year Established: | 1981 | Ticker: | AMAG | Exchange: | NASDAQ | Main Contact: | Nicholas Grung, Executive VP & CCO | | Other Contacts: | William Heiden, President & CEO Tony Casciano, Senior VP, Specialty Products Sales and Marketing Julie Krop, M.D., Executive VP & CMO Edward (Ted) Myles, Executive VP & CFO Shannon Gath, VP, Head of AMAG Technology Kathryn Carr Payne, Senior VP, Corporate Affairs Kyle Haraldsen, VP, Technical Operations and Project Management Joseph D. Vittiglio, Executive VP & Executive Vice President, General Counsel J. Alan Butcher, Executive VP & CBO Brian Robinson, M.D., Senior VP, Medical Affairs
| | Company Description | AMAG Pharmaceuticals is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Feraheme(TM) (ferumoxytol injection) is being developed for use as an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia and as a diagnostic agent for vascular-enhanced magnetic resonance imaging to assess peripheral arterial disease. | |
|
|
|
|
|